IDH1 may play a role in the development of intracranial lesions as it is not only involved in driving the formation of gliomas, but also can impair differentiation by increasing apoptosis in various central nervous system lineages, leading to neuronal defects. This evidence concerns the gene IDH1 and central nervous system cancer.